Anonymous
Guest
Anonymous
Guest
In regards to a mystery product, I have seen the new pump. Still kinda underwraps. It's actually pretty cool. Now I hope they execute it correctly.
In regards to a mystery product, I have seen the new pump. Still kinda underwraps. It's actually pretty cool. Now I hope they execute it correctly.
Dyloject training modules to be sent 12/24 and completed by 1/9/15.
Expected FDA approval early fourth quarter and launch by February.
I have been doing a pre-launch of my own with some AN's and am getting some very positive feedback. Price always comes up.....priced right it will sell wrong it will not be added to any formularies as most are on 0 increase with drug costs.
Hope you're listening marketing and Dennis. Screw this up and we are definitely in deep shit with no boots.
You will be lucky to see that product to 4th quarter 2015 and price is the only issue right now in hospitals.
In regards to a mystery product, I have seen the new pump. Still kinda underwraps. It's actually pretty cool. Now I hope they execute it correctly.
I am interviewing for an ACC position, and I have a question about future products. I hear rumors that there is some potential secret-squirrel product launch on the horizon for Hospira. Not Dyloject, its something in addition that would launchin 2013 or 2014, best I can tell... I have come across a few possible candidates in my research, but who knows if I am on the right track or not... Can anyone shed any light on this mystery product? Thanks in advance!
Tom here, You couldn't pull your tricks after salesforce.com was implemented
Did you ever get your back pay you fought so hard for Mr Wuss
Your old territory growth for the past 4 years since we terminated you increased 29%
Philadelphia/S.Jersey all talk about what a pompous ass you were and looking here
I see you haven't changed a bit
Get a life you loser. Not surprised you were/are a typical shit-for-brains HR lackey.
Bogus post or not, the responses are valid. Hospira utilizes the "mushroom theory", i.e keep everyone in the dark and feed them a lot of horse manure.
I doubt any vacant positions will be filled...just absorbed. Once generic, a product will hold maybe 50% of its market share for 6 mos. After that it's anyone's guess....all based on the price of the product, its position on the contracts,hospital/insurance formularies, etc.
The pre-fill will retain many customers, providing there isn't a premium price for it. ACC will undoubtedly keep all or most of the reps thru Dec. Then, based on how much generic erosion takes place for Precedex, you will definitely see an adjustment in numbers.
You HR morons simply take orders from upper mgmnt. You do what you are told to keep the company out of lawsuits. You distort truth, aka. LIE, to screw individuals. You know nothing but what you are told. Please, disappear from CP; you and your posts are very annoying.
Sales Management Guy
Kookie Goebbels Mires has a gold plated resume but is insufferably pompass and arrogant towards employees which only helps acidify the 'Swamp'. SLT are you listening? Hello? I can only assume you don't address this because you plan is to sell this rotten ship.
News Flash! Flash!
New product is on its way to us; it is dylodex!
Dyloject plus Precedex ...pain relief plus sedation. A potential blockbuster if it's marketed properly. We are working with Endo on this and it looks like a Q3 2015 launch date. Thank you Dennis and Kelly
Haaaaaaaaaaa
Launch date revised to first quarter
What a Fool, and a Tool ! Give it up ! Your creditability, like you, is a BIG ZERO on here !
Dyloject DONT have FDA Approval,Now crawl back under your rock lightweight